Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Efficacy of PosBion® Postbiotic Supplementation in Adults With Irritable Bowel Syndrome

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07699926
Title field or adapter rule
{'original_value': 'Efficacy of PosBion® Postbiotic Supplementation in Adults With Irritable Bowel Syndrome', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:35.076566+00:00
Published At
2026-07-14T00:00:00+00:00
Record Updated At
2026-07-14
Source Retrieved At
2026-10-31T22:18:48.933435+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["IBS (Irritable Bowel Syndrome)", "IBD (Inflammatory Bowel Disease)", "Gut Health"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-07-14", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT07699926"
protocolSection.identificationModule.officialTitle
"Efficacy of PosBion\u00ae Postbiotic Supplementation in Adults With Irritable Bowel Syndrome"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • IBS (Irritable Bowel Syndrome) (protocolSection.conditionsModule.conditions)
  • IBD (Inflammatory Bowel Disease) (protocolSection.conditionsModule.conditions)
  • Gut Health (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['PosBion® Postbiotic Supplementation'], 'description': 'PosBion® is a dietary postbiotic supplement containing inactivated Lactobacillus plantarum RS5 (2,500 mg) and Lactobacillus plantarum RI11 (2,500 mg) per sachet. Subjects consumed two sachets orally once daily for 12 weeks. The intervention was evaluated for its effects on IBS symptoms, quality of life, gastrointestinal health, intestinal inflammation, intestinal barrier integrity, mucosal immunity, oxidative stress, and gut-brain axis biomarkers.', 'name': 'Postbiotic supplementation', 'type': 'DIETARY_SUPPLEMENT'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.